Format

Send to

Choose Destination
Ann Oncol. 2018 Jun;29 Suppl 5:v109. doi: 10.1093/annonc/mdy149.025. Epub 2020 Jan 7.

Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy.

Author information

1
Oslo University Hospital, Oslo, Norway.
2
Uppsala University, Uppsala, Sweden.
3
Haukeland University Hospital, University of Bergen, Bergen, Norway.
4
Department of Oncology, Odense University Hospital, Odense, Denmark.
5
University of Oslo, Oslo, Norway.
6
Zealand Hospital, Roskilde, Roskilde, Denmark.
7
Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
PMID:
32177006
DOI:
10.1093/annonc/mdy149.025
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science Icon for Norwegian BIBSYS system
Loading ...
Support Center